Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Immunology Research
Cancer Immunology Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Categories of Articles

«  Visit AACR Journals' Instructions for Authors

SmartSubmit

The following types of articles will be considered for publication. Note that word counts are exclusive of references and Materials and Methods. Authors are advised that submissions not adhering to the guidelines provided below, including word counts, may be returned unreviewed. After completion of the review process, the Editors scientifically edit each article to improve their clarity, brevity, and quality.

Research Articles

Original studies offering broad impact across the entire discipline of cancer immunology including basic, pre-clinical, translational, and clinical investigations. The reports should be well-documented, novel, and significant to the field as a whole.

  • 250-word abstract
  • 5,000 words of text
  • 7 tables and/or figures (Please keep the number of panels per figure to an absolute minimum)
  • 50 references

Priority Briefs

Short, definitive reports of findings of high impact, significance, and timeliness. These reports receive an accelerated review. Papers submitted as Priority Briefs should include a section for Materials and Methods as well as Results and Discussion (Results and Discussion may be combined but Materials and Methods may not be combined with any other section).

  • 200-word abstract
  • 2,500 words of text
  • 4 tables and/or figures (Please keep the number of panels per figure to an absolute minimum)
  • 25 references

Cancer Immunology Miniatures

Miniatures are well-analyzed, provocative clinical cases or patient-based discovery that is immunologically insightful, yet not sufficiently developed for publication as a Research Article. These provide the basis for significant future research impacting clinical investigation and care.

  • 200-word abstract
  • 2,500 words of text
  • 4 tables and/or figures (Please keep the number of panels per figure to an absolute minimum)
  • 25 references

Review Articles (By Invitation Only)

Articles that review a timely subject important to those working in the field of cancer immunology. The length restrictions for this category of publication are provided below. Longer reviews will be considered at the discretion of the Editors.

  • 200-word abstract
  • 2,000 words of text
  • 1 original figure with a maximum of 4 panels
  • 30 references

Cancer Immunology at the Crossroads (By Invitation Only)

Perspectives that highlight the intersection of cancer immunology with other areas of cancer research and allied disciplines.

  • 250-word abstract
  • 2,500 words of text
  • 1 original figure with a maximum of 4 panels (figure to be redrawn)
  • 30 references

Masters of Immunology (By Invitation Only)

Primers on specific aspects of basic immunology that are of great relevance to cancer immunology. These short pieces by leading scientists are targeted to cancer researchers and physicians whose primary activities have not focused on immunology.

  • 250-word abstract
  • 2,500 words of text
  • 1 original figure with a maximum of 4 panels (figure to be redrawn)
  • 30 references

Letters to the Editor

Original correspondence comprised of scholarly commentary on subjects of importance and interest to the cancer immunology community, Letters to the Editor must relate to recently published Cancer Immunology Research articles. At the editors’ discretion, the Letter may be sent to various pertinent parties, including the author(s) of the cited article and other experts in the field, in order to grant them the opportunity to respond. Any such response would be vetted similarly and published in the same issue of the journal as the Letter.

  • Letter title should read as "'Running title of the original article'—Letter"
  • 500 words of text
  • 10 references. The first reference must cite the original article.
  • 1 figure and/or table. Display items are permitted only if they show data that refute the conclusions of the originating article; figures or tables featuring unpublished data in support of the conclusions of the originating article will not be considered.

Back to top


Cancer Immunology Research Editorial Office
American Association for Cancer Research  |  Publications Division
615 Chestnut Street  |  17th Floor  |  Philadelphia, PA 19106-4404
Phone: (215) 440-9300  |  Fax: (215) 446-7289  |  E-mail:  cancerimmunolres@aacr.org

Updated: 16 July 2016  10:30 am EST
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Cancer Immunology Essentials

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Immunology Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Immunology Research
eISSN: 2326-6074
ISSN: 2326-6066

Advertisement